Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger 
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit 
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest 
World game at war: why some European nations have threatened a World Cup boycott 
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow 
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer 
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests 
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations 
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality 
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation 
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints 
PLEASANTON, Calif., April 23, 2018 -- Title21 Health Solutions, “Title21”, a provider of cloud technology of Enterprise Quality Management Systems (EQMS) and innovative Cellular Therapy Software was awarded a ‘Best Places to Work’ honor for the second consecutive year by the San Francisco Business Times and Silicon Valley Business Times.
“This is a testament to our talented high-performing team and our culture of excellence and empathy. Title21 is dedicated to helping cure cancer and other life-threatening diseases. Our entire team is passionate about making a difference to advance immunotherapy and gene therapy to save lives. We are continuously innovating our technology solutions to better serve the therapies that leading biotech and healthcare institutions are advancing,” said Title21 Co-Founder and CEO, Lynn Fischer. “Our mission requires a strong sense of urgency to support these hopeful clinical breakthroughs, and our dedicated team delivers that excellent care. Title21 is a growing company where employees ‘connect their head and their heart’ in a culture where they can be lifelong learners and build a rewarding career that truly makes a difference.”
Title21’s Enterprise Quality Management Cloud is deployed at top U.S. hospitals, and Title21 launched the first end-to-end software for Blood and Marrow Transplants, Cell and Gene Therapy and Regenerative Medicine available in the market. “It is incredibly rewarding to work directly with the best institutions that are leading the development in cancer treatments for patients who need it most,” stated Dan Waurzyniak, Systems Architect.
Over 500 Bay Area companies participated in an independent, third-party survey that asked employees to grade their workplace anonymously on criteria such as culture, team dynamics, benefits, compensation, management practices and career development opportunities. Companies that make this list are known for having a purpose-driven mission as well as providing its employees with great compensation and a comprehensive benefits package. To learn more about making a difference at Title21 Health Solutions, please visit the Title21’s Careers Page: www.title21.com/careers.
About Title21 Health Solutions
Title21 Health Solutions continues to gain national recognition for its innovative technology to help hospitals, biotechnology and regenerative medicine improve quality, efficiency and patient safety. Title21 is hiring; visit www.Title21.com!
Media Contact Haley Roebuck [email protected]
